应用13-顺-视黄酸和干扰素-α治疗不可切除的头颈部复发癌

来源 :国外医学(耳鼻咽喉科学分册) | 被引量 : 0次 | 上传用户:sophia_je
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
不可切除的头颈部复发癌病例平均存活期大约5个月,姑息治疗往往无效,不能延长病人的存活期也不能减轻病人的巨大痛苦。作者试用13一顺一视黄酸和干扰素一a治疗不可切除的头颈部复发癌病例共16例,全部是当初采用手术及放疗后复发的病人,其中2例同时曾接受化疗。病变 Unresectable cases of recurrent cancer of the head and neck have an average survival time of approximately 5 months. Palliative care is often ineffective and does not extend the patient’s survival or relieve the patient’s immense suffering. The authors tested 13 cases of recurrent retinoic acid and IFN-a in the treatment of unresectable head and neck cancers in 16 cases, all of which were patients who relapsed after surgery and radiotherapy. Two of them had received chemotherapy at the same time. Lesion
其他文献